Immuneering Corporation (IMRX) Revenue 2020–2023
Immuneering Corporation (IMRX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$0FY2023 · since FY2020: $2.3M → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $0 | -100.0% |
| FY2022 | $316,952 | -84.8% |
| FY2021 | $2.1M | -10.0% |
| FY2020 | $2.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice